cysteine and Cerebral Infarction, Middle Cerebral Artery

cysteine has been researched along with Cerebral Infarction, Middle Cerebral Artery in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (75.00)29.6817
2010's2 (16.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Abdin, MZ; Ahmad, FJ; Ali, M; Beg, S; Fatima, S; Mishra, P; Parvez, S; Quadri, SN; Samim, M1
Behensky, AA; Cuevas, J; Garcia, A; Katnik, C; Petrov, AV; Seredenin, SB; Shuster, AM; Yasny, IE1
Agrawal, SK; Atif, F; Yousuf, S1
Ahmad, A; Ashafaq, M; Islam, F; Javed, H; Khan, A; Khan, MM; Khuwaja, G; Safhi, MM; Shadab Raza, S; Siddiqui, MS1
Harada, M; Hori, A; Nishitani, H; Uno, M1
Lu, CZ; Ren, HM; Xiao, BG; Zhang, RL1
Brinigar, WS; Fronticelli, C; Koehler, RC; Mito, T; Nemoto, M1
Chen, CP; Halliwell, B; Moore, PK; Qu, K; Wong, PT1
Chang, HM; Chen, CP; Chimon, GN; Halliwell, B; Ng, YK; Qu, K; Rumpel, H; Seah, AB; Wong, MC; Wong, PT1
Chu, LS; Fang, SH; Wang, ML; Wei, EQ; Ye, YL; Zhang, WP; Zhou, Y1
Doi, M; Konno, H; Ogasawara, K; Ogawa, A; Suzuki, M; Yoshimoto, T1
Doi, M; Ezura, M; Konno, H; Kuroda, K; Ogasawara, K; Ogawa, A; Yoshimoto, T1

Trials

1 trial(s) available for cysteine and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Prediction of acute embolic stroke outcome after local intraarterial thrombolysis: value of pretreatment and posttreatment 99mTc-ethyl cysteinate dimer single photon emission computed tomography.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2000, Volume: 20, Issue:11

    Topics: Adult; Aged; Brain Ischemia; Cysteine; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Infarction, Middle Cerebral Artery; Injections, Intra-Arterial; Intracranial Embolism; Male; Middle Aged; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2000

Other Studies

11 other study(ies) available for cysteine and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Crafting ɣ-L-Glutamyl-l-Cysteine layered Human Serum Albumin-nanoconstructs for brain targeted delivery of ropinirole to attenuate cerebral ischemia/reperfusion injury via "3A approach".
    Biomaterials, 2022, Volume: 289

    Topics: Antioxidants; Brain; Brain Ischemia; Cysteine; Dopamine; Humans; Indoles; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mitochondrial Permeability Transition Pore; Neuroprotective Agents; Reperfusion Injury; Serum Albumin, Human

2022
Activation of σ1 and σ2 receptors by afobazole increases glial cell survival and prevents glial cell activation and nitrosative stress after ischemic stroke.
    Journal of neurochemistry, 2016, Volume: 139, Issue:3

    Topics: Animals; Astrocytes; Benzimidazoles; Brain; Brain Ischemia; Butyrates; Cell Survival; Cysteine; Infarction, Middle Cerebral Artery; Macrophage Activation; Morpholines; Neuroglia; Neuroprotective Agents; Piperazines; Rats; Receptors, sigma; S-Nitrosothiols; Sigma-1 Receptor; Stroke; Tropanes

2016
S-allyl L-cysteine diminishes cerebral ischemia-induced mitochondrial dysfunctions in hippocampus.
    Brain research, 2009, Apr-10, Volume: 1265

    Topics: Animals; Blotting, Western; Brain Edema; Calcium; Cysteine; Cytochromes c; Electron Transport Chain Complex Proteins; Glutathione; Hippocampus; Hydrogen Peroxide; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Male; Mitochondria; Motor Activity; Neuroprotective Agents; Protein Carbonylation; Rats; Rats, Wistar; Reperfusion Injury; Severity of Illness Index

2009
S-allyl cysteine mitigates oxidative damage and improves neurologic deficit in a rat model of focal cerebral ischemia.
    Nutrition research (New York, N.Y.), 2012, Volume: 32, Issue:2

    Topics: Allium; Animals; Antioxidants; Behavior, Animal; Brain Ischemia; Cerebrum; Cysteine; Glial Fibrillary Acidic Protein; Infarction, Middle Cerebral Artery; Inflammation; Male; Nervous System Diseases; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Reperfusion Injury

2012
Evaluation of cerebral blood flow reserve in patients with cerebrovascular disease by SPECT using technetium-99m-L, L-ethyl cysteinate dimer.
    The journal of medical investigation : JMI, 2002, Volume: 49, Issue:3-4

    Topics: Acetazolamide; Adult; Aged; Carotid Stenosis; Cerebrovascular Circulation; Cysteine; Female; Humans; Image Processing, Computer-Assisted; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed, Single-Photon; Vertebrobasilar Insufficiency

2002
Metabolic changes of arachidonic acid after cerebral ischemia-reperfusion in diabetic rats.
    Experimental neurology, 2003, Volume: 184, Issue:2

    Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Blotting, Western; Brain Ischemia; Cyclooxygenase 2; Cysteine; Diabetes Mellitus, Experimental; Dinoprostone; Infarction, Middle Cerebral Artery; Isoenzymes; Leukotrienes; Male; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Reperfusion; Reverse Transcriptase Polymerase Chain Reaction

2003
Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse.
    Journal of applied physiology (Bethesda, Md. : 1985), 2006, Volume: 100, Issue:5

    Topics: Animals; Antioxidants; Blood Substitutes; Blood Transfusion; Brain Ischemia; Cattle; Cysteine; Erythrocytes; Escherichia coli; Hemoglobins; Humans; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Oxygen; Placebos; Reactive Oxygen Species; Recombinant Proteins; Salvage Therapy

2006
Hydrogen sulfide is a mediator of cerebral ischemic damage.
    Stroke, 2006, Volume: 37, Issue:3

    Topics: Air Pollutants; Animals; Brain Injuries; Brain Ischemia; Cerebral Cortex; Cysteine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Humans; Hydrogen Sulfide; Infarction, Middle Cerebral Artery; Male; Models, Statistical; Neuroprotective Agents; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Stroke; Time Factors; Treatment Outcome

2006
High plasma cyst(e)ine level may indicate poor clinical outcome in patients with acute stroke: possible involvement of hydrogen sulfide.
    Journal of neuropathology and experimental neurology, 2006, Volume: 65, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Animals; Brain; Cysteine; Cystine; Disease Models, Animal; Female; Humans; Hydrogen Sulfide; Infarction, Middle Cerebral Artery; Male; Middle Aged; Prognosis; Rats; Rats, Wistar; Stroke

2006
Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats.
    Acta pharmacologica Sinica, 2006, Volume: 27, Issue:9

    Topics: Animals; Antioxidants; Arachidonate 5-Lipoxygenase; Brain; Caffeic Acids; Cysteine; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Leukotriene B4; Leukotrienes; Male; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley

2006
Dynamic and static 99mTc-ECD SPECT imaging of subacute cerebral infarction: comparison with 133Xe SPECT.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:4

    Topics: Adult; Aged; Brain; Cysteine; Female; Humans; Infarction, Middle Cerebral Artery; Male; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Xenon Radioisotopes

2001